Xeris Pharmaceuticals Q3 EPS $(1.22) Down From $(0.71) YoY, Sales $314K Down From $582K YoY

Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(1.22) per share. This is a 71.83 percent decrease over losses of $(0.71) per share from the same period last year. The company reported $314 thousand in

Benzinga · 11/07/2019 14:53

Xeris Pharmaceuticals (NASDAQ:XERS) reported quarterly losses of $(1.22) per share. This is a 71.83 percent decrease over losses of $(0.71) per share from the same period last year. The company reported $314 thousand in sales this quarter. This is a 46.05 percent decrease over sales of $582 thousand the same period last year.